SC 13G: AN2 Therapeutics, Inc.
Ticker: ANTX · Form: SC 13G · Filed: Aug 12, 2024 · CIK: 1880438
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by AN2 Therapeutics, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 953 words · 4 min read · ~3 pages · Grade level 7.8 · Accepted 2024-08-12 16:48:14
Key Financial Figures
- $0.00001 — Inc. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class o
Filing Documents
- antx13g.htm (SC 13G) — 54KB
- 0001373604-24-000062.txt ( ) — 56KB
(a)
Item 1(a). Name of Issuer: AN2 Therapeutics, Inc.
(b)
Item 1(b). Address of Issuer's Principal Executive Offices: 1800 El Camino Real, Suite D, Menlo Park, California 94027
(a)
Item 2(a). Name of Person Filing: BML Investment Partners, L.P.
(b)
Item 2(b). Address of Principal Business Office or, if none, Residence: 65 E Cedar, Suite 2, Zionsville, IN 46077
(c)
Item 2(c). Citizenship: Delaware
(d)
Item 2(d). Title of Class of Securities: Common Stock, $0.00001 par value per share
(e)
Item 2(e). CUSIP Number: 037326105 Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ . Item 4. (a) Amount beneficially owned: 4,249,432 (b) Percent of class: 14.2 (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 4,249,432 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 4,249,432 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the c